Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals Net Common Equity Issued/Repurchased 2010-2025 | MDGL

Madrigal Pharmaceuticals annual/quarterly net common equity issued/repurchased history and growth rate from 2010 to 2025. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
  • Madrigal Pharmaceuticals net common equity issued/repurchased for the quarter ending March 31, 2025 was $0.009B, a 98.49% decline year-over-year.
  • Madrigal Pharmaceuticals net common equity issued/repurchased for the twelve months ending March 31, 2025 was $2.167B, a 80.47% increase year-over-year.
  • Madrigal Pharmaceuticals annual net common equity issued/repurchased for 2024 was $0.735B, a 38.57% increase from 2023.
  • Madrigal Pharmaceuticals annual net common equity issued/repurchased for 2023 was $0.53B, a 100.68% increase from 2022.
  • Madrigal Pharmaceuticals annual net common equity issued/repurchased for 2022 was $0.264B, a 55.3% increase from 2021.
  
Madrigal Pharmaceuticals Annual Net Common Equity Issued/Repurchased
(Millions of US $)
2024 $735
2023 $530
2022 $264
2021 $170
2020 $5
2019 $0
2018 $314
2017 $174
2016 $6
2015 $0
2014 $95
2013 $58
2012 $120
2011 $35
2010 $32
2009 $0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.005B $0.180B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $98.106B 36.80
Zoetis (ZTS) United States $70.247B 26.59
Daiichi Sankyo, - (DSNKY) Japan $49.445B 25.16
Takeda Pharmaceutical (TAK) Japan $48.747B 10.79
Summit Therapeutics (SMMT) United States $20.720B 0.00
Sandoz Group AG (SDZNY) Switzerland $19.545B 0.00
Merck (MKKGY) Germany $18.346B 15.18
Shionogi (SGIOY) Japan $14.436B 0.00
United Therapeutics (UTHR) United States $13.288B 11.76
Neurocrine Biosciences (NBIX) United States $10.852B 33.34
IPSEN (IPSEY) France $9.920B 0.00
Orion OYJ (ORINY) Finland $8.948B 24.20
Corcept Therapeutics (CORT) United States $7.717B 58.69
Stevanato Group S.p.A (STVN) Italy $6.475B 41.12
Ono Pharmaceutical (OPHLF) Japan $5.988B 12.26
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.813B 0.00
Ionis Pharmaceuticals (IONS) United States $5.217B 0.00
Grifols, S.A (GRFS) Spain $5.054B 0.00
Soleno Therapeutics (SLNO) United States $3.755B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.161B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.029B 12.30
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.470B 13.51
Hypermarcas (HYPMY) Brazil $2.350B 15.46
Recursion Pharmaceuticals (RXRX) United States $2.291B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.200B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.868B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Indivior (INDV) United States $1.652B 7.01
Guardian Pharmacy Services (GRDN) United States $1.632B 0.00
Evotec AG (EVO) Germany $1.523B 0.00
ARS Pharmaceuticals (SPRY) United States $1.420B 180.75
Ocular Therapeutix (OCUL) United States $1.402B 0.00
Dyne Therapeutics (DYN) United States $1.348B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.122B 45.61
Enliven Therapeutics (ELVN) United States $1.006B 0.00
Ardelyx (ARDX) United States $0.988B 0.00
Harrow (HROW) United States $0.948B 0.00
Collegium Pharmaceutical (COLL) United States $0.888B 4.72
Avadel Pharmaceuticals (AVDL) Ireland $0.840B 0.00
Xencor (XNCR) United States $0.801B 0.00
AleAnna (ANNA) United States $0.758B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.709B 0.00
KalVista Pharmaceuticals (KALV) United States $0.674B 0.00
Organogenesis (ORGO) United States $0.670B 0.00
Akebia Therapeutics (AKBA) United States $0.641B 0.00
Bioventus (BVS) United States $0.601B 15.62
Savara (SVRA) United States $0.587B 0.00
USANA Health Sciences (USNA) United States $0.555B 11.92
Relay Therapeutics (RLAY) United States $0.554B 0.00
Regulus Therapeutics (RGLS) United States $0.520B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.519B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.474B 0.00
Verve Therapeutics (VERV) United States $0.463B 0.00
Elite Pharmaceuticals (ELTP) United States $0.453B 0.00
Altimmune (ALT) United States $0.444B 0.00
Zevra Therapeutics (ZVRA) United States $0.437B 0.00
Tourmaline Bio (TRML) United States $0.419B 0.00
CytoDyn (CYDY) United States $0.405B 0.00
Siga Technologies (SIGA) United States $0.402B 6.87
Oruka Therapeutics (ORKA) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.352B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 20.60
Aquestive Therapeutics (AQST) United States $0.298B 0.00
Avita Medical (RCEL) United States $0.244B 0.00
Wellgistics Health (WGRX) United States $0.232B 0.00
ProKidney (PROK) United States $0.231B 0.00
Nature's Sunshine Products (NATR) United States $0.231B 27.15
Esperion Therapeutics (ESPR) United States $0.216B 27.25
OmniAb (OABI) United States $0.214B 0.00
Korro Bio (KRRO) United States $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.190B 0.00
MediWound (MDWD) Israel $0.186B 0.00
4D Molecular Therapeutics (FDMT) United States $0.174B 0.00
Aldeyra Therapeutics (ALDX) United States $0.168B 0.00
Inhibikase Therapeutics (IKT) United States $0.167B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Nanobiotix S.A (NBTX) France $0.157B 0.00
Profound Medical (PROF) Canada $0.157B 0.00
Aclaris Therapeutics (ACRS) United States $0.156B 0.00
Lexeo Therapeutics (LXEO) United States $0.154B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.151B 46.62
Procaps Group, S.A (PROCF) Luxembourg $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.140B 0.00
Protara Therapeutics (TARA) United States $0.138B 0.00
Lyell Immunopharma (LYEL) United States $0.136B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
OptiNose (OPTN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.089B 0.00
Galectin Therapeutics (GALT) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.080B 13.11
Unicycive Therapeutics (UNCY) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.078B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Cassava Sciences (SAVA) United States $0.078B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Telomir Pharmaceuticals (TELO) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Inotiv (NOTV) United States $0.068B 0.00
Karyopharm Therapeutics (KPTI) United States $0.063B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Vivani Medical (VANI) United States $0.062B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Avalo Therapeutics (AVTX) United States $0.055B 0.00
PMV Pharmaceuticals (PMVP) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.046B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
SCYNEXIS (SCYX) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Prelude Therapeutics (PRLD) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Surrozen (SRZN) United States $0.033B 0.00
PolyPid (PYPD) Israel $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
BioVie (BIVI) United States $0.022B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
Mannatech (MTEX) United States $0.020B 7.75
DURECT (DRRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Relmada Therapeutics (RLMD) United States $0.012B 0.00
TransCode Therapeutics (RNAZ) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 8.95
BioLineRx (BLRX) Israel $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 3.19
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Klotho Neurosciences (KLTO) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Incannex Healthcare (IXHL) Australia $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Heatwurx (PCSA) United States $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00